share_log

Plus Therapeutics | 8-K: Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

SEC ·  Aug 14 16:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more